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ORIGINAL ARTICLE

Reprogramming oral epithelial keratinocytes into a pluripotent
phenotype for tissue regeneration
Fayrouz Bazina1,2

|

Sabine M. Brouxhon3
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Abstract
Objectives: We set out to reprogram adult somatic oral epithelial keratinocytes into

2
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3

pluripotent cells for regenerative dentistry.
Setting and Sample population: Immortalized murine oral keratinocyte cell (IMOK)

Department of Physiology, School of
Medicine, Stony Brook University, Stony
Brook, New York, USA

line raised from adult mouse mucosa were cultured in vitro in our studies.

4

treated with TGF-β1 in vitro, and the expression of Oct4, Nanog, Sox2 and Nestin, as
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Materials and Methods: Adult murine oral epithelial keratinocytes were chronically
well as specific homeobox Gata and Pax gene family members were investigated.
Results: We documented the induction of stem factors linked with pluripotency

Correspondence
Stephanos Kyrkanides, UK Chandler Hospital,
Dental Wing D-132, 800 Rose Str. Lexington,
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and/or the maintenance and regulation of stem-cell self-renewal in oral epithelial
keratinocytes by TGFβ1. Moreover, we discovered that this TGF-β1-induced increase
in Oct4, Nanog, Sox2 and Nestin was inhibited by SB431542, suggesting that TGFβ1 signals via the TGF-βRI receptor to induce pluripotency and stemness.
Conclusions: Adult oral epithelial keratinocytes treated chronically with TGF-β1
acquired phenotypic characteristics consistent with pluripotent stem cells, highlighting the facileness of reprogramming adult oral keratinocytes into an unlimited supply
of pluripotent stem cells.
KEYWORDS

dedifferentiation, oral epithelium, stemness, TGFβ
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I N T RO DU CT I O N

abundantly line the oral cavity, as a source of cells for regenerative
dentistry.

Regenerative dentistry efforts aiming to restore oral, dental and cra-

Recent studies suggest that adult somatic cells exhibit remarkable

niofacial tissues impacted by injury or disease is a promising field with

plasticity, and can be reprogrammed to acquire pluripotency or stem

future clinical applications. Considerable progress has been made in

cell-like properties (Chakravarti et al., 2014). Such pluripotent cells

producing whole teeth, or parts of a tooth, or even biomimetic dental

can then be differentiated towards lineage-specific cell types so as to

materials (Galler & D'Souza, 2011; Mitsiadis et al., 2015). Although

replace damaged or diseased tissues and organs (Chakravarti

recent advances in the field of regenerative dentistry are promising,

et al., 2014). Pluripotent cells are a transient population of cells that

one significant limitation continues to be the inadequate supply of

depend on transcription factors, such as Oct4, Nanog and Sox2, to

cells needed in tissue and organ regeneration (Niibe et al., 2017).

maintain pluripotency, whilst simultaneously repressing lineage speci-

Therefore, the purpose of our study is to interrogate the repro-

fication (Chambers et al., 2007). Octamer-binding protein 4 (Oct4)

gramming potential of adult oral epithelial keratinocytes, which

was the first master gene shown to be required for pluripotency of

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2021 The Authors. Clinical and Experimental Dental Research published by John Wiley & Sons Ltd.
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murine and human pluripotent stem cells (Zeineddine et al., 2014). As

Upon reaching 40% confluency, cells were treated with 5 ng/ml

such, Oct4 is well accepted as a core pluripotency factor in associa-

recombinant mouse TGF-β1 (Bazina et al., 2021; Valcourt et al., 2005)

tion with its partner transcription factors, Nanog and Sox2 (Shi &

(R&D System), or equal volumes of vehicle, for 2-, 4, and 6-days. For

Jin, 2010). Genetic studies report that the core pluripotent genes,

TGF-βRI inhibitory experiments, the solid anhydrous TGF-βRI kinase

Oct4, Nanog and Sox2, are highly expressed in stem cells (Huang &

inhibitor SB-431542 (TOCRIS) was added to the culture media

Garcia-Godoy, 2017). Moreover, cells losing Oct4 during murine

(10 μM final concentration).

embryonic development were found to differentiate into somatic cells
(Pesce & Scholer, 2001). Sox2 further plays an essential role in
maintaining cells in this undifferentiated state and facilitating lineage
commitment

during

embryonic

development

2.2
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Immunofluorescence (IF)

(Carrasco-Garcia

et al., 2016). The unique ability of Sox2 to cooperate with Oct4 at

Cells were cultured on Lab-Tek chamber slides (Nalgene Nunc Inter-

specific binding sites is also critical for reprogramming fully differenti-

national) until 40% confluent before treatment with either TGF-β1 or

ated somatic cells into induced pluripotent cells (Aksoy et al., 2013).

vehicle control, at the indicated time points. Cells were fixed with 4%

Nanog also has been considered another key factor in the generation

formaldehyde and processed for immunofluorescence microscopy

of iPSCs, as addition of Nanog to Yamanaka factors (Hanna

(Kyrkanides et al., 2012). Primary antibodies included Oct4 and Nanog

et al., 2009), which include Oct4, Sox2, Klf4, and c-Myc, has been

(Abcam), Nestin (Novus Biologicals), counter stained with DAPI

shown to enhance the reprograming kinetics (Hanna et al., 2009). Yu

(Vector Laboratories). Images of cover slipped slides were captured

et al. (2007) demonstrated that Nanog and Oct4, along with Lin28

under 594 nm (red) and 350 nm (blue) wavelengths using a BX51

and Sox2, induced the de-differentiation of human fibroblasts into

Olympus fluorescent microscope.

pluripotent stem cells, with the full capacity to differentiate into any
cell type. In contrast, Nestin belongs to class VI intermediate filament
proteins, and is widely used as a marker of stem cells that are capable

2.3
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Flow cytometry

of multilineage differentiation (Chen et al., 2006).
Transforming growth factor beta (TGF-β1) is considered a key

Samples were prepared as described previously (Al-Attar et al., 2018).

component of the stem cell niche in many different tissues and

Briefly, harvested cells were fixed with 2% paraformaldehyde, washed

appears to play an essential role in modulating epithelial cell plasticity

with permeabilization buffer (BioLegend) and incubated with primary

and pluripotency. TGF-β1 has been reported to upregulate

antibodies: Oct4 (Chemicon), Nanog (Cell Signaling), Sox2 (Santa Cruz

pluripotency transcription factors in adult somatic cell lines in vitro.

Biotechnology), Nestin (Novus Biologicals), and Rabbit IgG (Abcam)

To this end, Au et al. (2015) showed that TGF-β1 induced the expres-

and chicken IgY isotype (R&D Systems) controls. After rinsing, cells

sion of Oct4 in primary human endometriotic stromal cells. Further-

were incubated with an Alexa flour-488 goat anti-rabbit secondary

more, TGF-β1 upregulated Nestin in human kidney proximal tubules

antibody (Molecular Probes), or a FITC goat anti-chicken IgY (Novus

cells (Wen et al., 2012) and in ventricular fibroblasts (Hertig

Biologicals) isotype control. Stained samples were read on an LSR-II

et al., 2017). However, it remains unclear whether TGF-β1 can induce

cytometer using FACSDiva version 6 (BD Biosciences) and analyzed

pluripotency in adult oral epithelial keratinocytes.

by FlowJo Software (TreeStar; version 9.5). Data are represented as

In the present study, we investigated whether chronic TGF-β1 is

geometric mean-fluorescence intensity (GMFI).

capable of reprogramming an immortalized murine oral keratinocyte
cell (IMOK) line developed from the oral mucosal specimens of adult
mice into a phenotype that expresses one or more of the key

2.4
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Western blotting

pluripotency transcription factors, in vitro.
Cells were processed for western blotting, as described previously
(Brouxhon et al., 2007). Briefly, samples were electrophoretically sepa-

2
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rated using SDS-PAGE, and transferred to nitrocellulose membranes.
Membranes were blocked with 5% (w/v) nonfat dry milk to block non-

2.1
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Cell culture and reagents

specific binding, and then incubated with TGF-βRI, TGF-βRII, Sox2 and
β-actin (Santa Cruz Biotechnology), Oct4 (Chemicon), Nestin (Novus

The Immortalized Murine Oral Keratinocytes (IMOK) cell line was

Biologicals), Nanog, TGF-βRIII, phospho-specific Smad2, Smad3, Smad2,

kindly donated by Dr. Garrett-Sinha at SUNY-Buffalo (Parikh

Smad3, and Smad4 (Cell signaling). Proteins were detected using appro-

et al., 2008) as part of NIH's Resource Sharing plan for funded investi-

priate HRP-conjugated secondary antibodies (Santa Cruz Biotechnol-

gators. Specifically, the IMOK cells were raised from tissue containing

ogy). Immunoreactive bands were detected using the Clarity MaxTM

oral epithelium from the buccal and palatal regions were harvested

Western ECL Substrate (Bio-Rad), and visualized using the ChemiDoc

from 6 month old female 129Sv mice. Cells were seeded in serum-

MP Imaging System (Bio-Rad). Western blot signals were normalized to

free keratinocyte media (CnT-02; CELLnTEC; Advanced Cell System)

β-actin, using NIH Scion Image. Results are presented as fold increase

and maintained at 37 C in a humidified chamber containing 5% CO2.

relative to controls in triplicate experiments.

3
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Cytokine array

results show that IMOK cells secrete into the conditioned media,
compared to control media, high levels of TGF-α (2.3-fold), IGFBP-4

The secretion of cytokines was evaluated using a Cytokine Antibody Array

(Insulin-like Growth Factor-Binding Protein 4; 2.5-fold), G-CSF

C1 Series (RayBiotech), according to the manufacturer's instructions. Briefly,

(Granulocyte Colony-Stimulating Factor; 2.6-fold), and SCFR (Stem

conditioned medium was obtained after culturing cells for 48 h in serum-free

Cell Factor Receptor/c-Kit; 4.5-fold) (Figure 1a). We further assessed

medium at 37 C and 5% CO2. Each array was incubated with 1 ml of

TGF-β1 levels in conditioned media at the 2-, 4-, and 6- day time



undiluted medium at 4 C overnight, washed, and then incubated with a bio-

points by ELISA. In agreement with the cytokine array, levels of TGF-

tinylated antibody cocktail, followed by an HRP-streptavidin incubation. To

β1 were negligible (40 pg/ml) at all-time points examined

determine the level of cytokines in the media, spot signal densities were mea-

(Figure 1b), suggesting that IMOK cells constitutively secrete low

sured using Image Studio™ Lite (LI-COR Biosciences), and data analysis was

levels of TGF-β1 under basal conditions.

®

performed using the RayBiotech Microsoft Excel-based analysis software.

2.6
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TGF-β1 ELISA

3.2 | Chronic TGF-β1 induced the upregulation of
pluripotency markers in IMOK cells

A commercial ELISA kit for secreted TGF-β1 (Biolegend) was used to

We characterized the stem cell transcriptome of IMOK cells in

quantify concentrations in cell culture supernatants according to the

response to TGF-β1 by a quantitative real-time PrimePCR array (Bio-

manufacturer's instructions.

Rad; custom-designed plates) including a panel of stem cell-associated
genes in total RNA extracted from TGF-β1 treated and vehicle control
groups, at the 2-, 4-, and 6-day time points. In our analysis, we

2.7
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Stem cell gene array

selected genes that showed at least a 1.5-fold up-regulation by TGFβ1, compared to vehicle controls. Our results indicate that TGF-β1

A custom-plate Prime-PCR mouse-stem cell gene array (SAB target list-

upregulated 10 out of the 29 genes at the time-points examined. Spe-

M96; Bio-Rad) was used to analyze the expression of the stem cell

cifically, TGF-β1 upregulated Pax6, Hoxb1, Hoxb13, and Hoxc12

signaling-associated genes in IMOK cells, treated in the presence or
absence of TGF-β1. RNA was extracted from cells using the RNeasy Mini
Kit (Qiagen), and RNA reversed transcribed using the iScript Advanced
cDNA Synthesis kit (Bio-Rad). The reaction mix was prepared using the
Advanced Universal SYBR® Green Supermix (Bio-Rad), per the manufacturer's instructions. For real-time polymerase chain reaction (qRT-PCR), a
CFX96 Touch Detection System (Bio-Rad) was used. For data normalization, stable reference genes, such as glyceraldehyde-3-phosphate dehydrogenase (GAPDH), was embedded in the plate setup and employed for
Δ-Cq calculations. cDNA templates were assayed in triplicates, and results
presented as relative gene expression (ΔΔ-Cq Expression) in the TGF-β1
treated groups normalized to the corresponding vehicle control samples.

2.8
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Statistical analysis

All data are shown as the means ± SEM. To determine statistical differences between or among means, a student's t-test was performed
where applicable. For all analyses, a p-value equal to or less than 0.05
was considered statistically significant.

3
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RESULTS

3.1 | Characterization of secreted cytokines from
naive IMOK cultures in vitro
We performed a comprehensive analysis of the secretome of IMOK
cells at baseline conditions using an antibody-based ELISA array. Our

F I G U R E 1 Characterization of cytokines released by naïve IMOK
cells. (a) Array analysis of growth factors released in the supernatants
of naïve IMOK cells in culture compared to fresh media (control) at
2-days post seeding (n = 2). (b) The concentration of active TGF-β1
was assessed by ELISA collected from naïve IMOK supernatants at 2-,
4- and 6-days post seeding. The results are shown as the mean ± SEM
in triplicate experiments

4
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genes in 2-day cultures, while Hoxb13, Hoxd1, and Oct4 (Pou5f1)

and 6-days in vitro. Densitometric analysis of the immunoreactive

genes were increased by day 4 (Figure 2a,b). Furthermore, the core

bands, normalized to their corresponding loading controls, revealed

pluripotency markers Oct4 (Pou5f1) and Nanog, as well as other

that Oct4, Nanog, Sox2 and Nestin were significantly increased in

stemness-related genes, including Hoxb1, Hoxb13, Hoxc4, Hoxc12,

response to TGF-β1 (Figure 3a). Specifically, immunoblot analysis

Hoxd1, Pax9, and Gata1 were significantly increased by day

showed a statistically significant increase in Oct4 levels, that peaked

6 (Figure 2a–c). Notably, only Hoxb13 gene revealed a persistent

at 4-days. In contrast, Nanog, Sox2 and Nestin peaked at the 6-day

TGF-β1-induced up-regulation over the three-time points examined

time point. Next, we assessed the spatiotemporal localization of Oct4,

(Figure 2d).

Nanog and Nestin after chronic TGF-β1 treatment by immunofluores-

Changes in the stem cell transcription factors Oct4, Nanog, Sox2

cence. Consistent with our western blotting results, we observed an

and Nestin were next evaluated at the protein level by western blot-

intensification of immunostaining in response to TGF-β1 treatment

ting, in response to chronic TGF-β1 treatment in IMOK cells at 2-, 4-,

over time (Figure 3b). Additionally, Oct4 and Nanog demonstrated

F I G U R E 2 Pluripotency,
Gata1 and Homeobox gene
changes in IMOK cells after
chronic TGF-β1 treatment. A
primePCR stem cells gene array
(BioRad) was used to evaluate
relative gene expression profiles
of IMOK cells after chronic TGFβ1 treatment. (a) Clustergram
demonstrating differentially
expressed pluripotency, Gata1
and Homeobox genes in IMOK
cells treated with TGF-β1, or
vehicle control, for 2-, 4-, and
6-days after normalizing to
GAPDH. Red indicates greater
expression, green indicates lower
expression Cq > 30. The data of
the representative genes were
derived from three independent
experiments. (b) Bar graph
showing relative expression of
selected Gata1 and Homeobox
genes that have >1.5-fold
increase in the ΔΔCq expression
after 2-, 4-, and 6-days chronic
treatment with TGF-β1, versus
their corresponding vehicle
controls. (c) Gene levels of Oct4
and Nanog at the selected time
points. (d) Venn diagram
illustrating distinct and
overlapping gene expression for
the up-regulated genes in 2-day
(blue), 4-day (Orange), and 6-day
(Gray) TGF-β1 treated IMOK cells
relative to their vehicle control
group. Experiments were
conducted in triplicates. Data are
presented as mean + SEM;
*p < 0.05; **p < 0.01;
***p < 0.001

5
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F I G U R E 3 Oct4, Sox2, Nanog and Nestin
induction in IMOK cells after chronic TGF-β1
in vitro. (a) Representative immunoblot and
analysis of the expression levels of Oct4, Sox2,
Nanog and Nestin in total cell lysates from IMOK
cells treated chronically with TGF-β1 versus
vehicle controls at the indicated time points by
western immunoblotting. Expression levels were
normalized to β-actin and quantitated by NIH
Scion Image. (b) Representative
immunofluorescence images for Oct4, Nanog and
Nestin (red) in control and TGFβ1-treated cells at
the indicated times. Nuclei were labeled with
DAPI (blue). Data are presented as mean + SEM.
*p < 0.05, **p < 0.01, versus corresponding
control (n = 3). Bar = 20 μm

strong nuclear staining in the TGF-β1-treated cells which peaked at

phenotypical changes in adult oral keratinocytes associated with the

6-days, compared to controls. Similarly, Nestin immunostaining was

upregulation and nuclear localization of the key master transcription

weak in control conditions, but demonstrated a strong TGF-

factors Oct4, Nanog, Sox2, as well upregulation of other markers

β1-induced nuclear and perinuclear localization at 4 days (Figure 3b).

involved in the maintenance of this undifferentiated state and regula-

Taken together, these data suggest that chronic TGF-β1 induces

tion of stem cell self-renewal.

6
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3.3 | Expression of TGF-β1 cognate receptors are
induced by TGF-β1 in IMOK cells

3.4 | TGF-β1 upregulation of pluripotency markers
in IMOK cells is through TGF-βRI

We examined whether chronic TGF-β1 modulates TGF-β receptor

We explored whether chronic TGF-β1 induces the upregulation of

family members (Miyazono et al., 1993) in IMOK cells by western

pluripotency factors in IMOK cells through the TGF-βRI receptor

blotting. TGF-β1-treated IMOK cells showed a significant induc-

through the use of the selective antagonist SB431542 as follows:

tion of TGF-βRI and TGF-βRII expression compared to controls

(1) vehicle control; (2) TGF-β1; (3) TGF-β1 + SB431542; and

but exhibited no effect on TGF-βRIII at 2-, 4-, or 6-days

(4) SB431542 (10 μM) alone. Flow cytometry analyses confirmed that

(Figure 4a–c). It is well established that TGF-β1 binds to the TGF-

TGF-βRI

β receptor complexes to activate downstream Smad signaling

pluripotency markers by TGF-β1 in IMOK cells (Figure 5a–d). Taken

(Parikh et al., 2008). Therefore, we next sought to determine

together, our data suggest that chronic TGF-β1, via its cognate receptor

whether TGF-β1 signals via canonical Smad signaling by western

TGF-βRI, can induce stem cell factors in IMOK cells.

inhibitor

SB431542

attenuated

the

upregulation

of

blotting in these cells. Our results show a statistically significant
increase in phospho-specific Smad2 levels at 2-days after TGF-β1
treatment, whereas no alterations were noted at the 4- and 6-day

4

|

DI SCU SSION

time-points (Figure 4d). Similarly, phospho-Smad3 levels were significantly increased at 2- and 4-days following TGF-β1 treatment

A new source of cells with stem-like properties is required for regen-

(Figure 4e).

erative dentistry in the future. In the present study, we evaluated

F I G U R E 4 Modulation of the TGFβ1-Smad2/3 axis in IMOK cells following chronic
TGF-β1 treatment. Representative western blots
and analysis of (a) TGF-βRI, (b) TGF-βRII and
(c) TGF-βRIII protein levels in whole lysates
prepared from IMOK cells, in the presence or
absence of TGF-β1. (d) Representative western
blots and corresponding analyses of
phosphorylated and total levels of Smad2 and
(e) Smad3 in IMOK cells, in the presence or
absence of TGF-β1. Protein levels were normalized
to β-actin and quantitated by NIH Scion image.
Data are presented as mean, SEM. *p < 0.05;
**p < 0.01; TGF-β1 versus control (n = 3)

7
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F I G U R E 5 TGF-β1-induced stemness is mediated in part by TGFβ1-RI in IMOK cells in vitro. The stem cell markers (a) Oct4, (b) Nanog (c),
Sox2, and (d) Nestin were evaluated by flow cytometry in IMOK cells treated chronically with TGF-β1, in the presence or absence of the TGF-β1
receptor inhibitor SB431542 at the indicated time points. Bar charts analyses represent quantification of the GMFI means for each marker in the
vehicle-control (ctrl), TGF-β1, TGF-β1 with the TGF-β receptor inhibitor (TGF-β1 + SB431542) and the TGF-β receptor inhibitor (SB431541) only
conditions. Results are presented as mean ± SEM. n = 3. *Significant compared to control; #significant compared to TGF-β1 treated. Statistical
significance was evaluated by student's t-test (*, #p < 0.05; **, ##p < 0.01; ***, ###p < 0.001)

whether adult somatic oral epithelial keratinocytes, lining the oral cav-

can serve as the starting cell type in the generation of enamel-like bio-

ity, can be successfully reprogrammed to acquire pluripotent stem

mimetic material as recently described (Bazina et al., 2021).

cell-like properties, thereby providing a practically unlimited supply of

A recent body of evidence suggests that similar to embryonic

stem-like cells that could be differentiated into tissues for regenera-

stem cells, fully differentiated somatic cells can be reprogrammed into

tive efforts. For example, reprogrammed oral epithelial keratinocytes

a more primitive state, highlighting many questions about the

8
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reversible nature of somatic cell reprogramming and induction of

induction of Hox, Pax, and Gata genes has yet to be reported in adult

pluripotency (Takahashi & Yamanaka, 2006; Yu et al., 2007).

somatic cells elsewhere.

Reprogramming adult somatic cells into a pluripotent state can

We also report that TGF-β1 induced the expression of Oct4,

yield iPSCs (Buganim et al., 2013). Intriguingly, iPSCs, which have

Nanog, Sox2 and Nestin in IMOK cells through activation of the TGFβ

the capacity to differentiate into multiple cell types, have been

receptor type I (TGFβR-I) and downstream Smad2/3 intracellular sig-

generated from adult somatic cells by ectopic expression of an

naling. Previous reports have shown that SB431542 led to a reduction

interconnected network of pluripotent transcription factors,

in Oct4 and Nanog expression, although Nanog expression was more

including but not limited to, Oct4, Sox2, Klf4, c-Myc, Nanog or

sensitive to this loss of signaling (Greber et al., 2008). In addition, inhi-

Lin28 (Takahashi et al., 2007; Takahashi & Yamanaka, 2006; Yu

bition of TGF-β1 signaling, via SB-431542, was able to drastically

et al., 2007). High levels of Oct4 during the initial reprogramming

deprive “stemness features” of glioma-initiating cells and promote

stage was reported as sufficient to generate iPSCs from adult

their differentiation (Peñuelas et al., 2009; Valcourt et al., 2005). Addi-

somatic cells (Radzisheuskaya & Silva, 2014). In addition, Oct4

tionally, the role of TGF-β1 in upregulating or maintaining

overexpression together with small molecule agents was sufficient

pluripotency markers, including Oct4 and Nanog, through Smad trans-

to reprogram fibroblasts into iPSCs (Salci et al., 2015) and cells co-

duction signaling has been reported in a number of transformed cell

expressing Oct4 and Nanog exhibited a more stable pluripotent

lines (Bae et al., 2016). Noteworthy, both Oct4 and Nanog also form a

state than cells individually expressing these factors alone

complex with Smad2, and/or Smad3 in mouse and human embryonic

(Theunissen et al., 2011). Overexpression of Sox2 in mouse and

stem cells (Mullen & Wrana, 2017).

human fully differentiated fibroblasts, was further shown to estab-

The field of regenerative Dentistry has developed recently and

lish multipotent-induced neuronal stem cells (Ring et al., 2012).

efforts to produce an abundant source of cells for the production of

The unique ability of Sox2 to cooperate with Oct4 at specific bind-

stem-like cells has been the focus of several investigators. For exam-

ing sites is critical for the reprogramming of fully differentiated

ple, Yamasaki et al. (2014) were successful in developing human plu-

somatic cells into iPSCs (Aksoy et al., 2013). Thus, together, Oct4

ripotent stem cells using as starting material dental pulp tissue.

and Sox2 preserve an equilibrium in cell fate decisions, which ren-

However, the relative small amount of pulp tissue and the need to

ders pluripotency (Thomson et al., 2011). Although Nestin is not

sacrifice a healthy tooth for their harvest significantly limits the clinical

considered one of the core stem cell transcription factors, human

application of this method. In contrast, the facileness of harvesting

and mouse Nestin-expressing stem cells in the hair follicle bulge

adult somatic cells, together with the versatility of generating pluripo-

were able to produce neurons, glia, keratinocytes, smooth muscle

tent cells with chronic TGF-β1, opens up exciting opportunities to

cells, blood cells and melanocytes in vitro (Yashiro et al., 2015)

tackle regenerative challenges linked to the repair of enamel, or other

suggesting a multipotent phenotype with putative therapeutic

types of mineralized tissues. To this end, IMOK cells reprogrammed

potential.

by TGF-β1 have been successfully employed recently in the produc-

Our data demonstrate that chronic TGF-β1 treatment of the

tion of an enamel biomimetic material (Bazina et al., 2021).

immortalized murine oral epithelial keratinocyte cell line IMOK
induced the expression of Oct4, Nanog, Sox2 and Nestin in vitro. Their
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